RXSIGHT INC. - COMMON STOCK

RxSight, Inc. Reports Third Quarter 2024 Financial Results

07 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

24 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

22 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Second Quarter 2024 Financial Results

05 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

22 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. To Participate in the Truist Securities Medtech Conference

05 Jun 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

13 May 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

08 May 2024 21:15:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Proposed Public Offering of Common Stock

08 May 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports First Quarter 2024 Financial Results

06 May 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the Bank of America Healthcare Conference

01 May 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

22 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting

04 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference

27 Mar 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference

29 Feb 2024 19:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

28 Feb 2024 16:05:01 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 

14 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

07 Jan 2024 10:00:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

27 Dec 2023 16:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Third Quarter 2023 Financial Results

09 Nov 2023 16:05:00 By Nasdaq GlobeNewswire